• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双(吲哚基)酮腙-腙的设计与合成:发现强效和高选择性的新型微管蛋白抑制剂。

Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.

机构信息

Department of Chemistry, Birla Institute of Technology and Science, Pilani 333 031, India.

Department of Natural Sciences, University of Houston - Downtown, Houston, TX 77002, United States.

出版信息

Eur J Med Chem. 2017 Aug 18;136:184-194. doi: 10.1016/j.ejmech.2017.04.078. Epub 2017 May 3.

DOI:10.1016/j.ejmech.2017.04.078
PMID:28494255
Abstract

A novel series of ketohydrazide-hydrazones as analogues of naturally occurring coscinamides has been synthesized and evaluated for their anticancer activity against five cancer cell lines. Of the twenty-synthesized ketohydrazide-hydrazones, compounds, 21c, 21f, 21g, 21k and 21o showed cytotoxic effects (less than 50% cell survival) against multiple cancer cell lines when tested at a final concentration of 10 μM. IC of three compounds 21f, 21k and 21o was determined to be less than 5 μM for all tested cancer cell lines. Compound 21k exhibited significant anticancer activity against MCF-7, MDA-MB-231, HCT-116 and JURKAT cancer cell lines with IC values of 0.8 μM, 0.50 μM, 0.15 μM, and 0.22 μM, respectively. Also, 21k was found to be more selectively cytotoxic against tumor cells when compared to normal cells. Preliminary mechanism of action studies indicated that the most active compound 21k induced caspase-dependent apoptosis in cells. 21k arrests cell cycle in G2/M phase by inhibiting of tubulin polymerization (IC = 0.6 μM).

摘要

已经合成了一系列新型的酮腙-腙类似物作为天然存在的柯西酰胺的类似物,并对其针对五种癌细胞系的抗癌活性进行了评估。在所合成的二十个酮腙-腙中,当终浓度为 10μM 时,化合物 21c、21f、21g、21k 和 21o 对多种癌细胞系表现出细胞毒性作用(细胞存活率低于 50%)。三种化合物 21f、21k 和 21o 的 IC 在所有测试的癌细胞系中均小于 5μM。化合物 21k 对 MCF-7、MDA-MB-231、HCT-116 和 JURKAT 癌细胞系表现出显著的抗癌活性,IC 值分别为 0.8μM、0.50μM、0.15μM 和 0.22μM。此外,与正常细胞相比,21k 对肿瘤细胞的细胞毒性更具选择性。初步作用机制研究表明,最活跃的化合物 21k 在细胞中诱导了 caspase 依赖性细胞凋亡。21k 通过抑制微管蛋白聚合将细胞周期阻滞在 G2/M 期(IC=0.6μM)。

相似文献

1
Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.双(吲哚基)酮腙-腙的设计与合成:发现强效和高选择性的新型微管蛋白抑制剂。
Eur J Med Chem. 2017 Aug 18;136:184-194. doi: 10.1016/j.ejmech.2017.04.078. Epub 2017 May 3.
2
Novel bis(indolyl)hydrazide-hydrazones as potent cytotoxic agents.新型双(吲哚基)腙-腙类化合物作为有效的细胞毒试剂。
Bioorg Med Chem Lett. 2012 Jan 1;22(1):212-5. doi: 10.1016/j.bmcl.2011.11.031. Epub 2011 Nov 16.
3
Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.具有新型连接基的双异吲哚啉腙类化合物:作为细胞毒性剂的合成与生物学评价
Eur J Med Chem. 2016 Jan 27;108:415-422. doi: 10.1016/j.ejmech.2015.11.047. Epub 2015 Dec 2.
4
Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells.新型双(吲哚基)-酰肼-腙衍生物作为针对A549肺癌细胞的强效微管靶向细胞毒性剂的开发。
Biochemistry. 2016 May 31;55(21):3020-35. doi: 10.1021/acs.biochem.5b01127. Epub 2016 May 19.
5
Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.新型康普瑞汀 A-4 硫代衍生物的设计、合成及作为微管靶向剂的生物评价。
Eur J Med Chem. 2018 Jan 20;144:797-816. doi: 10.1016/j.ejmech.2017.11.050. Epub 2017 Dec 12.
6
Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.新型苯并三唑 N-酰基芳腙杂合体的设计、合成及抗癌活性、对细胞周期谱的影响、caspase-3 介导的细胞凋亡和 FAK 抑制作用。
Bioorg Chem. 2018 Oct;80:531-544. doi: 10.1016/j.bioorg.2018.07.008. Epub 2018 Jul 10.
7
Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors.黄酮类喹啉类似物的合成及生物评价作为潜在的抗癌剂和微管蛋白聚合抑制剂。
Eur J Med Chem. 2016 May 23;114:14-23. doi: 10.1016/j.ejmech.2016.02.069. Epub 2016 Mar 2.
8
Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors.噻唑并吲哚-3-基-2-氧代乙酰胺衍生物的合成及其作为微管蛋白聚合抑制剂的活性。
Eur J Med Chem. 2017 Sep 29;138:83-95. doi: 10.1016/j.ejmech.2017.06.025. Epub 2017 Jun 15.
9
Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.一系列含吲哚基团的吡喃查尔酮衍生物作为新型抗微管蛋白剂的设计、合成及生物学评价
Bioorg Med Chem. 2014 Apr 1;22(7):2060-79. doi: 10.1016/j.bmc.2014.02.028. Epub 2014 Mar 1.
10
Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.姜黄素激发的咪唑并[1,2-a]吡啶类似物作为微管蛋白聚合抑制剂的合成及生物学评价
Eur J Med Chem. 2018 Jan 1;143:216-231. doi: 10.1016/j.ejmech.2017.11.010. Epub 2017 Nov 5.

引用本文的文献

1
Synthesis, , evaluation of furanyl- and thiophenyl-3-phenyl-1-indole-2-carbohydrazide derivatives as tubulin inhibitors and anticancer agents.呋喃基和噻吩基-3-苯基-1-吲哚-2-碳酰肼衍生物作为微管蛋白抑制剂和抗癌剂的合成、 及评价 。 (注:原英文文本中“evaluation”前多了个逗号,表述有误)
RSC Med Chem. 2024 May 28;15(7):2483-2495. doi: 10.1039/d4md00210e. eCollection 2024 Jul 17.
2
Design, synthesis and anticancer activity of N-aryl indolylsulfoximines: Identification of potent and selective anticancer agents.设计、合成及抗癌活性的 N-芳基吲哚基亚磺酰基胺:鉴定有效的和选择性的抗癌剂。
Bioorg Med Chem. 2023 Oct 1;93:117459. doi: 10.1016/j.bmc.2023.117459. Epub 2023 Aug 24.
3
Novel -Acyl Hydrazone Compounds as Promising Anticancer Agents: Synthesis and Molecular Docking Studies.
新型酰腙化合物作为有前景的抗癌剂:合成与分子对接研究
ACS Omega. 2023 May 20;8(22):20073-20084. doi: 10.1021/acsomega.3c02361. eCollection 2023 Jun 6.
4
Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines.2-芳氧基苯甲醛 N-酰腙和 1,3,4-恶二唑衍生物的细胞毒性活性及对接研究及其对各种癌细胞系的作用。
Molecules. 2022 Oct 27;27(21):7309. doi: 10.3390/molecules27217309.
5
Design and synthesis of novel ureido and thioureido conjugated hydrazone derivatives with potent anticancer activity.具有强效抗癌活性的新型脲基和硫脲基共轭腙衍生物的设计与合成。
BMC Chem. 2022 Nov 1;16(1):81. doi: 10.1186/s13065-022-00873-3.
6
Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).基于靶点的抗癌吲哚衍生物及其构效关系洞察:机制综述更新(2018 - 2021年)
Acta Pharm Sin B. 2022 Jul;12(7):3006-3027. doi: 10.1016/j.apsb.2022.03.021. Epub 2022 Apr 1.
7
Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5(4)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site.噻唑-5(4)-酮作为靶向秋水仙碱结合位点的潜在微管蛋白聚合抑制剂的设计、环保合成、分子建模及抗癌评估
RSC Adv. 2020 Jan 15;10(5):2791-2811. doi: 10.1039/c9ra10094f. eCollection 2020 Jan 14.
8
A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.靶向微管蛋白聚合的分子杂化物的最新进展综述
Int J Mol Sci. 2022 Apr 4;23(7):4001. doi: 10.3390/ijms23074001.
9
Exploration of Novel Tubulin Inhibitors: A Combination of Docking and Molecular Dynamics Simulations, Pharmacophore Modeling, and Virtual Screening.新型微管蛋白抑制剂的探索:基于对接和分子动力学模拟、药效团建模和虚拟筛选的组合方法。
Comput Math Methods Med. 2022 Jan 15;2022:4004068. doi: 10.1155/2022/4004068. eCollection 2022.
10
Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.吲哚基噁二唑衍生物的合成、分子对接和β-葡萄糖醛酸酶抑制潜力。
Molecules. 2019 Mar 8;24(5):963. doi: 10.3390/molecules24050963.